Related references
Note: Only part of the references are listed.PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma
Tetsuhiro Kasamatsu et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Clinical role of serum programmed death ligand 1 in patients with hepatocellular carcinoma: Where does it come from?
Hatem A. Elmezayen et al.
SURGERY TODAY (2020)
Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma
Minh Phuong Dong et al.
SCIENTIFIC REPORTS (2020)
Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment
Juan Xia et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer
Guoliang Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure
Jose Avendano-Ortiz et al.
MEDICINE (2020)
Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Emmanuel Acheampong et al.
CELLS (2020)
PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
Xiao Fu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma
Xue Han et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
Guenther Schoenrich et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
Mohammad Hashemi et al.
CANCERS (2019)
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
Alexandre P. Benechet et al.
NATURE (2019)
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
Boyang Chang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus
Nghiem Xuan Hoan et al.
BMC MEDICAL GENETICS (2019)
Association of PD-L1 gene rs4143815 C > G polymorphism and human cancer susceptibility: A systematic review and meta-analysis
Ju Zou et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
C. Van Berckelaer et al.
BREAST CANCER RESEARCH (2019)
Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer
Dan Tan et al.
CANCER BIOMARKERS (2018)
Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population
Qigui Xie et al.
GENE (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer
Calogerina Catalano et al.
PLOS ONE (2018)
Clinical significance of soluble programmed cell death ligand-1 (sPD-L1) in hepatocellular carcinoma patients treated with radiotherapy
Hyun Ju Kim et al.
RADIOTHERAPY AND ONCOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
PD-1 and its ligands are important immune checkpoints in cancer
Yinan Dong et al.
ONCOTARGET (2017)
Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer
Shin Yup Lee et al.
GENE (2017)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C
Satoshi Yamagiwa et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer
Yusuke Okuma et al.
LUNG CANCER (2017)
Variant SNPs at the microRNA complementary site in the B7-H1 3'-untranslated region increase the risk of non-small cell lung cancer
Wenwen Du et al.
MOLECULAR MEDICINE REPORTS (2017)
The Prognostic Significance of Soluble Programmed Death Ligand 1 Expression in Cancers: A Systematic Review and Meta-analysis
Y. Ding et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
Xinxin Zhu et al.
ONCOTARGET (2017)
Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients
Rasoul Nasiri Kalmarzi et al.
ALLERGOLOGY INTERNATIONAL (2017)
Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
Changqing Ma et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
Fabian Finkelmeier et al.
EUROPEAN JOURNAL OF CANCER (2016)
Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features
Julien Calderaro et al.
HEPATOLOGY (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy
Shin Yup Lee et al.
SCIENTIFIC REPORTS (2016)
Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection
Q. Zheng et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
B. Ye et al.
CELL DEATH & DISEASE (2015)
Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma
Liang Wang et al.
ONCOTARGET (2015)
Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma
Ian-James Malm et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients
Shenyou Sun et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Restoration of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
Bertram Bengsch et al.
JOURNAL OF HEPATOLOGY (2014)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Benjamin J. Chen et al.
CLINICAL CANCER RESEARCH (2013)
A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma
Weipeng Wang et al.
HUMAN GENETICS (2013)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Barbara Rehermann
NATURE MEDICINE (2013)
Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma
Myoung Jae Kang et al.
TRANSLATIONAL ONCOLOGY (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis
Chun-Ming Wong et al.
HEPATOLOGY (2012)
Soluble B7-H1: Differences in production between dendritic cells and T cells
Xavier Frigola et al.
IMMUNOLOGY LETTERS (2012)
Living in the liver: hepatic infections
Ulrike Protzer et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma
Xavier Frigola et al.
CLINICAL CANCER RESEARCH (2011)
Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines
Yongjing Chen et al.
CYTOKINE (2011)
MicroRNA-29b Suppresses Tumor Angiogenesis, Invasion, and Metastasis by Regulating Matrix Metalloproteinase 2 Expression
Jian-Hong Fang et al.
HEPATOLOGY (2011)
Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
Zhen Zeng et al.
PLOS ONE (2011)
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Paola Fisicaro et al.
GASTROENTEROLOGY (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA-122, a Tumor Suppressor MicroRNA that Regulates Intrahepatic Metastasis of Hepatocellular Carcinoma
Wei-Chih Tsai et al.
HEPATOLOGY (2009)
Many roads to maturity: microRNA biogenesis pathways and their regulation
Julia Winter et al.
NATURE CELL BIOLOGY (2009)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
Claire Dunn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers
Zhenbao Yu et al.
NUCLEIC ACIDS RESEARCH (2007)
The immune response during hepatitis B virus infection
Antonio Bertoletti et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Systematic review: the model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?
E Cholongitas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
JN Stoop et al.
HEPATOLOGY (2005)
Translation of immunological knowledge into better treatments of chronic hepatitis B
A Bertoletti et al.
JOURNAL OF HEPATOLOGY (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Share Paper
